Document 0610 DOCN M95A0610 TI Response to trivalent influenza vaccine in children vertically infected with HIV. American Pediatric Society 104th annual meeting and Society for Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle. DT 9510 AU Tressler RL; King JC; Batlas S; Stancliff C; Farley JI; Vink PE; Univ. of Md. Hosp., Dept. of Pediatrics, Balto., USA. SO Pediatr AIDS HIV Infect. 1994 Oct;5(5):320 (unnumbered abstract). Unique Identifier : AIDSLINE AIDS/95330434 AB The CDC recommends that all individuals > 6 months of age receive trivalent inactivated influenza (Flu) vaccine if they or a household member is HIV infected. However, there is limited data on the immunologic response to Flu vaccine in HIV-infected children. We report data on the serologic response of children exposed to HIV in utero. During the fall of 1991 and 1992, 27 HIV infected (mean age 39, range 6.3 to 97 months) and 18 HIV (-) children born to HIV (+) mothers (mean age 36, range 8.2 to 80 months) were recruited and immunized with Flu vaccine according to CDC guidelines. Hemagglutination inhibition (HAI) titers were measured on sera obtained just prior to and 3 to 16 weeks post-vaccination. The change in HAI titers (log2 post - log2 pre) were compared between HIV (+) and HIV (-) children using Wilcoxon Rank Sum. The proportion of children with > or = 4-fold rise in HAI titers (vaccine responders) were compared using Fisher's exact. CDC clinical HIV classification (P1 or P2), immunologic parameters (lymphocyte subsets and total IgG levels) were compared in HIV positive vaccine responders and non-responders using Wilcoxon Rank Sum. The mean rise in log2 HAI titers (increases titer) and % with 4-fold increase (% rise) in HAI titers are shown below. There was no significant difference between Flu vaccine responders and non-responders based upon CDC classification or immunologic parameters. TABULAR DATA, SEE PUBLISHED ABSTRACT. Although HIV infected children respond to Flu vaccine, as demonstrated by rise in HAI titer, the magnitude of the response is significantly decreased compared to HIV (-) children. Neither clinical HIV class nor immunologic parameters predicted response to Flu vaccine. DE Antibodies, Viral/ANALYSIS *Disease Transmission, Vertical Hemagglutination Inhibition Tests Human HIV Infections/*IMMUNOLOGY/TRANSMISSION Infant Influenza Vaccine/*IMMUNOLOGY Orthomyxovirus Type A, Human/IMMUNOLOGY Orthomyxoviruses Type B/IMMUNOLOGY MEETING ABSTRACT JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).